Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial
Clinical and Molecular Hepatology · 2025
DOI: 10.3350/cmh.2024.0640 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical and Molecular Hepatology, 2025. Verfasst von Yao-Chun Hsu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, E-Da Hospital, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Alanine Transaminase, Antiviral Agents, Tenofovir. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Gilead Sciences, E-Da Hospital, Ministry of Science and Technology, Taiwan.
Abstract (Originalsprache)
Background/Aims: Treatment indications for patients with chronic hepatitis B (CHB) remain contentious, particularly for patients with mild alanine aminotransferase (ALT) elevation. We aimed to evaluate treatment effects in this patient population.
Methods
This rollover study extended a placebo-controlled trial that enrolled non-cirrhotic patients with CHB and ALT levels below two times the upper limit of normal. Following 3 years of randomized intervention with either tenofovir disoproxil fumarate (TDF) or placebo, participants were rolled over to open-label TDF for 3 years. Liver biopsies were performed before and after the treatment to evaluate histopathological changes. Virological, biochemical, and serological outcomes were also assessed (NCT02463019).
Results
Of 146 enrolled patients (median age 47 years, 80.8% male), 123 completed the study with paired biopsies. Overall, the Ishak fibrosis score decreased in 74 (60.2%), remained unchanged in 32 (26.0%), and increased in 17 (13.8%) patients (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, E-Da Hospital, Kaohsiung, Taiwan.
- School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Fu-Jen Catholic University Hospital, Fu-Jen Catholic University, New Taipei, Taiwan.
- Institute of Biomedical Informatics, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Division of Gastroenterology and Hepatology, Chia-Yi Christian Hospital, Chia-Yi, Taiwan.
- Division of Gastroenterology and Hepatology, E-Da Cancer Hospital, Kaohsiung, Taiwan.
Förderung
- Gilead Sciences
- E-Da Hospital
- Ministry of Science and Technology, Taiwan
Zitieren
APA
Hsu, Y. C., Chen, C. Y., Tseng, C. H., Chen, C. C., Lee, T. Y., Bair, M. J., Chen, J. J., Huang, Y. T., Chang, I. W., Chang, C. Y., Wu, C. Y., Wu, M. S., Mo, L. R., & Lin, J. T. (2025). Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2024.0640
Vancouver
Hsu YC, Chen CY, Tseng CH, Chen CC, Lee TY, Bair MJ, et al. Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial. Clinical and Molecular Hepatology. 2025. doi:10.3350/cmh.2024.0640
BibTeX
@article{Hsu2025,
author = {Hsu, Yao-Chun and Chen, Chi-Yi and Tseng, Cheng-Hao and Chen, Chieh-Chang and Lee, Teng-Yu and Bair, Ming-Jong and Chen, Jyh-Jou and Huang, Yen-Tsung and Chang, I-Wei and Chang, Chi-Yang and Wu, Chun-Ying and Wu, Ming-Shiang and Mo, Lein-Ray and Lin, Jaw-Town},
title = {Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial},
journal = {Clinical and Molecular Hepatology},
year = {2025},
doi = {10.3350/cmh.2024.0640}
}
EUVIMED